Loading...

John Teerlink, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
AddressVAMC 203
San Francisco CA 94121
Phone415-221-4810 ext. 24160
ORCID ORCID Icon0000-0001-9527-0852 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Swarthmore College, Swarthmore, PABA with Highest Honors1983Comparative Religious Studies/ Cellular and Molecular Biology
    Harvard Medical School, Boston, MAM.D.1988Medicine
    University of California, San Francisco, San Francisco, CAInternal Medicine Residency 1991Internal Medicine
    F. Hoffmann-La Roche, LTD (Basel, Switzerland, Basel, SwitzerlandPost-Doctoral Fellowship1993Cardiovascular Pharmacology
    University of California, San Francisco, San Francisco, CA Clinical Cardiology Fellowship 1995Cardiovascular Medicine
    Collapse Awards and Honors
    Swarthmore College1981Holmes Prize in Religion
    Swarthmore College1983Holmes Prize in Religion
    Swarthmore College1983Phi Beta Kappa
    American Heart Association/ Harvard Medical School1986  - 1987Medical Student Research Fellowship Award
    UCSF1990Alpha Omega Alpha Nominee, Outstanding House Officer Teacher
    UCSF1995Alpha Omega Alpha Nominee, Outstanding House Officer Teacher
    Department of Veterans Affairs, VISN 212000Veterans Affairs Young Investigators Research Award
    United States Food and Drug Administration2008Advisory Committee Service Award
    UCSF2010UCSF Clinical Cardiology Fellow’s Teaching Award

    Collapse Overview 
    Collapse Overview
    Dr. John R. Teerlink, F.A.C.C., F.A.H.A., F.E.S.C., F.H.F.A., F.H.F.S.A., F.R.C.P.(UK) is Director of Heart Failure and of the Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California. He graduated from Swarthmore College with Highest Honors in Comparative Religious Studies and Cellular Biology. After receiving his medical degree from Harvard Medical School, where he performed a year of research in the laboratory of Drs. Janice and Marc Pfeffer, he completed an internal medicine residency at the University of California San Francisco (UCSF). He continued his basic science training through a post-doctoral research fellowship at Hoffman-LaRoche in Basel, Switzerland with Drs. Martine and Jean-Paul Clozel. Dr. Teerlink completed his cardiovascular medicine fellowship and a Howard Hughes post-doctoral research fellowship at UCSF, subsequently joining the faculty, where he currently is a Professor of Clinical Medicine.

    He is actively involved in the design and execution of many acute and chronic heart failure clinical trials, serving on endpoint, data safety monitoring, and steering committees for numerous international studies investigating a variety of new therapies, including tezosentan (RITZ program, VERITAS), levosimendan (REVIVE 1&2), nesiritide (ASCEND-HF), serelaxin (Pre-RELAX-AHF, RELAX-AHF, RELAX-AHF-2, RELAX-ASIA, RELAX-Repeat), rolofylline (PROTECT), omecamtiv mecarbil (CY1111, CY1121, ATOMIC-AHF, COSMIC-HF, GALACTIC-HF, METEORIC-HF), TRV027 (BLAST-AHF), warfarin/ clopidogrel/ aspirin (WATCH, WARCEF), nitroxyl donor (STANDUP-AHF), fineranone (FIGARRO, FIDELIO), LCZ696 (sacubitril/ valsartan; PARADIGM-HF), and empagliflozin (EMPEROR-Preserved, EMPEROR-Reduced, DINAMO), as well as stem cell therapies (CHART-1) and diagnostic modalities, such as CardioMEMS device (CHAMPION, CardioMEMS Post-approval Study), left atrial pressure sensor (LAPTOP-HF) and other devices (ADAPT-Response). He serves as a consultant on clinical development programs in multiple areas of cardiology, as well as in cardiovascular safety for non-cardiovascular indications.

    Dr. Teerlink has been an active member of the Heart Failure Society of America, serving on many committees including the Membership, Scientific Program, Corporate Affairs, Development, Lifetime Achievement Award and Guideline Committees and currently serves as Secretary and on the Board of Directors and the Executive Council. He also currently serves on the Acute Heart Failure Committee of the European Society of Cardiology Heart Failure Association and has served on the National Committee on Heart Failure and Transplantation of the American Heart Association. He is a founding and charter member of the American Association of Heart Failure Nurses. Dr. Teerlink completed a four-year term as a permanent member of the United States Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee, and frequently serves as an ad hoc member of multiple other FDA advisory committees and panels for medical devices, diagnostics, biologics and drugs. He is a member of the joint FDA/ Duke University Standardized Data Collection for Cardiovascular Clinical Trials Initiative to develop standardized definitions for cardiovascular endpoints. He was an Associate Editor for the Journal of Cardiac Failure, is currently the Guest Editor-in-Chief for JACC: Heart Failure, and is a clinical scholar presenting many lectures and publications, including a chapter on Acute Heart Failure in Braunwald’s Heart Disease textbook. He was profiled in The Lancet as an internationally recognized leader in heart failure.

    Collapse Research 
    Collapse Research Activities and Funding
    EMPULSE: A multicentre, randomised, double-blind, 90-day superiority trial to evaluate the effect on clinical benefit, safety and tolerability of once daily oral EMPaglilozin 10 mg compared to placebo, initiated in patients hospitalised for acUte decompensated heartfaiLure who have been StabilisEd. (EudraCT 2019-002946-19)
    Boerhinger-Ingelheim Jan 1, 2019
    Role: International Coordinating Investigator and Member, Executive Committee
    Novel adrenergic mechanisms in heart failure therapy
    VA I01BX004314Oct 1, 2018 - Sep 30, 2022
    Role: Principal Investigator
    DINAMO: A Double-blind, Randomised, Placebo-controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of Empagliflozin and Linagliptin Over 26 Weeks, With a Double-blind Active Treatment Safety Extension Period up to 52 Weeks, in Children and Adolescents With Type 2 Diabetes Mellitus. (NCT03429543)
    Boerhinger-Ingelheim Jan 1, 2018
    Role: Member, Clinical Events Committee
    SOLVE-CRT: Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients. (NCT02922036)
    EBR Systems Inc. Jan 1, 2017
    Role: Member, Clinical Events Committee
    EMPEROR-Reduced: A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction. EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure. (EudraCT 2016-002280-34)
    Boerhinger-Ingelheim Jan 1, 2017
    Role: Member, Clinical Events Committee
    ANTHEM-HFrEF Pivotal Study: Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction. (NCT03425422)
    LivaNova Jan 1, 2017
    Role: Member, Executive Committee
    EMPEROR-Preserved: A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction. EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure. (EudraCT 2016-002278-11)
    Boerhinger-Ingelheim Jan 1, 2017
    Role: Member, Clinical Events Committee
    STANDUP-AHF: Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure. (NCT03016325)
    Bristol-Myers Squibb Mar 1, 2016
    Role: Steering Committee Member
    GALACTIC-HF: Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure. (NCT02929329)
    Amgen/ Cytokinetics/ Servier Nov 1, 2015
    Role: Trial Principal Investigator; Executive Committee Chairperson
    FIGARO-DKD: FInerenone in reducinG cArdiovascular moRtality and mOrbidity in Diabetic Kidney Disease
    Bayer Nov 1, 2015
    Role: Clinical Events Committee Member
    FIDELIO-DKD: FInerenone in reducing kiDnEy faiLure and dIsease prOgression in Diabetic Kidney Disease
    Bayer Nov 1, 2015
    Role: Clinical Events Committee Member
    CardioMEMS PAS: CardioMEMS HF System Post Approval Study
    St. Jude/ Abbott Apr 1, 2015
    Role: Clinical Events Committee Member
    ADAPT-Response: AdaptResponse Clinical Trial
    Medtronic Jul 1, 2014
    Role: Clinical Events Committee Member
    BLAST-AHF: Biased Ligand of the Angiotensin II Type 1 Receptor in Patients with Acute Heart Failure
    Trevena, Inc Aug 1, 2013
    Role: Steering Committee Member
    RELAX-REPEAT
    Novartis May 1, 2013
    Role: Trial Principal Investigator
    RELAX-AHF-Asia: Evaluating the Efficacy, Safety, and Tolerability of Serelaxin when Added to Standard Therapy in Asian Patients with Acute Heart Failure
    Novartis Apr 1, 2013
    Role: Steering Committee Member
    RELAX-AHF-2: Serelaxin in addition to standard therapy in acute heart failure
    Novartis Sep 1, 2012
    Role: Trial Co-Principal Investigator/ Executive Committee Co-Chairperson
    COSMIC-HF: Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
    Amgen/ Cytokinetics Sep 1, 2012
    Role: Trial Principal Investigator; Executive Committee Chairperson
    CHART: Congestive Heart failure Cardiopoietic Regenerative Therapy
    Celyad Jul 1, 2012
    Role: Clinical Events Committee Chairperson; Publication Committee Member
    PARADIGM-HF: A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
    Novartis May 15, 2010
    Role: Co-US National Leader
    LAPTOP-HF: Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
    St. Jude Apr 1, 2010 - Dec 31, 2015
    Role: Clinical Events Committee Member

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory. JACC Heart Fail. 2020 Dec 09. Bhatt AS, Abraham WT, Lindenfeld J, Bristow M, Carson PE, Felker GM, Fonarow GC, Greene SJ, Psotka MA, Solomon SD, Stockbridge N, Teerlink JR, Vaduganathan M, Wittes J, Fiuzat M, O'Connor CM, Butler J. PMID: 33309582.
      View in: PubMed   Mentions:    Fields:    
    2. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study. JACC Heart Fail. 2020 Nov 24. Felker GM, McMurray JJV, Cleland JG, O'Connor CM, Teerlink JR, Voors AA, Belohlavek J, Böhm M, Borentain M, Bueno H, Cole RT, DeSouza MM, Ezekowitz JA, Filippatos G, Lang NN, Kessler PD, Martinez FA, Mebazaa A, Metra M, Mosterd A, Pang PS, Ponikowski P, Sato N, Seiffert D, Ye J. PMID: 33248986.
      View in: PubMed   Mentions:    Fields:    
    3. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 11 17; 76(20):2368-2378. Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Bhatt AS, Carson PE, Cleland JGF, Felker GM, Januzzi JL, Kitzman DW, Leifer ES, Lewis EF, McMurray JJV, Mentz RJ, Solomon SD, Stockbridge N, Teerlink JR, Vaduganathan M, Vardeny O, Whellan DJ, Wittes J, Anker SD, O'Connor CM. PMID: 33183511.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium. JACC Heart Fail. 2020 Dec; 8(12):961-972. Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O'Connor CM. PMID: 33199251.
      View in: PubMed   Mentions:    Fields:    
    5. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N Engl J Med. 2020 Nov 13. Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE. PMID: 33185990.
      View in: PubMed   Mentions: 3     Fields:    
    6. Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients with Chronic Heart Failure: Results from the COSMIC-HF Study. Circ Heart Fail. 2020 Nov 12. Felker GM, Solomon SD, McMurray JJV, Cleland JGF, Abbasi SA, Malik FI, Zhang H, Globe G, Teerlink JR. PMID: 33176437.
      View in: PubMed   Mentions:    Fields:    
    7. The Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure (COSMIC-HF). Circ Heart Fail. 2020 Nov 12. Biering-Sørensen T, Minamisawa M, Claggett B, Liu J, Felker GM, McMurray JJV, Malik FI, Abbasi S, Kurtz CE, Teerlink JR, Solomon SD. PMID: 33176443.
      View in: PubMed   Mentions:    Fields:    
    8. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. JACC Heart Fail. 2020 Dec; 8(12):999-1008. Loungani RS, Teerlink JR, Metra M, Allen LA, Butler J, Carson PE, Chen CW, Cotter G, Davison BA, Eapen ZJ, Filippatos GS, Gimpelewicz C, Greenberg B, Holbro T, Januzzi JL, Lanfear DE, Pang PS, Piña IL, Ponikowski P, Miller AB, Voors AA, Felker GM. PMID: 33189635.
      View in: PubMed   Mentions:    Fields:    
    9. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials. Eur J Heart Fail. 2020 Nov; 22(11):2160-2171. Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria Correa LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Abbasi SA, Varin C, Malik FI, Kurtz CE. PMID: 32985088.
      View in: PubMed   Mentions:    Fields:    
    10. Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes. ESC Heart Fail. 2020 Oct 23. Bartunek J, Terzic A, Davison BA, Behfar A, Sanz-Ruiz R, Wojakowski W, Sherman W, Heyndrickx GR, Metra M, Filippatos GS, Waldman SA, Teerlink JR, Henry TD, Gersh BJ, Hajjar R, Tendera M, Senger S, Cotter G, Povsic TJ, Wijns W. PMID: 33094909.
      View in: PubMed   Mentions: 1     Fields:    
    11. Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial. Circulation. 2020 Oct 21. Packer M, Anker SD, Butler J, Filippatos GS, Ferreira JP, Pocock S, Carson PE, Anand IS, Doehner W, Haass M, Komajda M, Miller AB, Pehrson S, Teerlink JR, Brueckmann M, Jamal W, Zeller C, Schnaidt S, Zannad F. PMID: 33081531.
      View in: PubMed   Mentions:    Fields:    
    12. Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction. Eur J Heart Fail. 2020 Oct 09. Alhakak AS, Sengeløv M, Jørgensen PG, Bruun NE, Johnsen C, Abildgaard U, Iversen AZ, Hansen TF, Teerlink JR, Malik FI, Solomon SD, Gislason G, Biering-Sørensen T. PMID: 33034122.
      View in: PubMed   Mentions:    Fields:    
    13. Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium. Eur J Heart Fail. 2020 Oct 05. Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O'Connor CM. PMID: 33017862.
      View in: PubMed   Mentions:    Fields:    
    14. Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 study. Eur J Heart Fail. 2020 Sep 22. Feng S, Janwanishstaporn S, Teerlink JR, Metra M, Cotter G, Davison B, Felker GM, Filippatos G, Pang P, Ponikowski P, Sama IE, Voors AA, Greenberg B. PMID: 32964537.
      View in: PubMed   Mentions:    Fields:    
    15. Drug development in oncology and devices-lessons for heart failure drug development and approval? a review. Heart Fail Rev. 2020 Sep 16. Davison BA, Cotter G, Filippatos GS, Zannad F, Voors AA, Metra M, Teerlink JR, Senger S, Mebazaa A, Greenberg B. PMID: 32939666.
      View in: PubMed   Mentions:    Fields:    
    16. Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology. Circulation. 2020 Aug 25; 142(8):790-798. Psotka MA, Fiuzat M, Solomon SD, Chauhan C, Felker GM, Butler J, Teerlink JR, Sinha SS, O'Connor CM, Konstam MA. PMID: 32833519.
      View in: PubMed   Mentions:    Fields:    
    17. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117. Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, Lindenfeld J, McMurray JJV, Mehra M, Metra M, Packer M, Pieske B, Pocock SJ, Ponikowski P, Rosano GMC, Teerlink JR, Tsutsui H, Van Veldhuisen DJ, Verma S, Voors AA, Wittes J, Zannad F, Zhang J, Seferovic P, Coats AJS. PMID: 32498081.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    18. Assessing the lifetime benefit of heart failure therapies. Lancet. 2020 07 11; 396(10244):75-77. Psotka MA, Teerlink JR. PMID: 32446325.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Aug; 22(8):1298-1314. Harjola VP, Parissis J, Bauersachs J, Brunner-La Rocca HP, Bueno H, Celutkiene J, Chioncel O, Coats AJS, Collins SP, de Boer RA, Filippatos G, Gayat E, Hill L, Laine M, Lassus J, Lommi J, Masip J, Mebazaa A, Metra M, Miró Ò, Mortara A, Mueller C, Mullens W, Peacock WF, Pentikäinen M, Piepoli MF, Polyzogopoulou E, Rudiger A, Ruschitzka F, Seferovic P, Sionis A, Teerlink JR, Thum T, Varpula M, Weinstein JM, Yilmaz MB. PMID: 32347648.
      View in: PubMed   Mentions: 1     Fields:    
    20. Endpoints in Heart Failure Drug Development: History and Future. JACC Heart Fail. 2020 06; 8(6):429-440. Fiuzat M, Lowy N, Stockbridge N, Sbolli M, Latta F, Lindenfeld J, Lewis EF, Abraham WT, Teerlink J, Walsh M, Heidenreich P, Bozkurt B, Starling RC, Solomon S, Felker GM, Butler J, Yancy C, Stevenson LW, O'Connor C, Unger E, Temple R, McMurray J. PMID: 32278679.
      View in: PubMed   Mentions: 2     Fields:    
    21. Mega-trials in heart failure: effects of dilution in examination of new therapies. Eur J Heart Fail. 2020 Sep; 22(9):1698-1707. Davison BA, Takagi K, Senger S, Koch G, Metra M, Kimmoun A, Mebazaa A, Voors AA, Nielsen OW, Chioncel O, Pang PS, Greenberg BH, Maggioni AP, Cohen-Solal A, Ertl G, Sato N, Teerlink JR, Filippatos G, Ponikowski P, Gayat E, Edwards C, Cotter G. PMID: 32227620.
      View in: PubMed   Mentions: 2     Fields:    
    22. Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial. Eur J Heart Fail. 2020 Apr; 22(4):726-738. Janwanishstaporn S, Feng S, Teerlink J, Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Pang P, Ponikowski P, Severin T, Gimpelewicz C, Holbro T, Chen CW, Sama I, Voors AA, Greenberg BH. PMID: 32141161.
      View in: PubMed   Mentions:    Fields:    
    23. Systolic time intervals in patients with heart failure: time to teach new dogs old tricks. Eur J Heart Fail. 2020 Jul; 22(7):1183-1185. Njoroge JN, Teerlink JR. PMID: 32056362.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    24. Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF. JACC Heart Fail. 2020 04; 8(4):329-340. Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Legg JC, Büchele G, Varin C, Kurtz CE, Malik FI, Honarpour N. PMID: 32035892.
      View in: PubMed   Mentions: 5     Fields:    
    25. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020 02; 7(1):75-83. Anand IS, Konstam MA, Klein HU, Mann DL, Ardell JL, Gregory DD, Massaro JM, Libbus I, DiCarlo LA, Udelson JJE, Butler J, Parker JD, Teerlink JR. PMID: 31984682.
      View in: PubMed   Mentions: 3     Fields:    
    26. Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial. Eur J Heart Fail. 2020 Sep; 22(9):1684-1693. Carubelli V, Zhang Y, Metra M, Lombardi C, Felker GM, Filippatos G, O'Connor CM, Teerlink JR, Simmons P, Segal R, Malfatto G, La Rovere MT, Li D, Han X, Yuan Z, Yao Y, Li B, Lau LF, Bianchi G, Zhang J. PMID: 31975496.
      View in: PubMed   Mentions: 2     Fields:    
    27. Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis. Eur J Heart Fail. 2020 02; 22(2):315-329. Teerlink JR, Davison BA, Cotter G, Maggioni AP, Sato N, Chioncel O, Ertl G, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Edwards C, Senger S, Teichman SL, Nielsen OW, Voors AA, Metra M. PMID: 31886953.
      View in: PubMed   Mentions: 4     Fields:    
    28. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. Circulation. 2019 12 17; 140(25):2108-2118. Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL, Jessup M, Kalyani RR, Kaul S, Kosiborod M, Lindenfeld J, McGuire DK, Sabatine MS, Solomon SD, Teerlink JR, Vaduganathan M, Yancy CW, Stockbridge N, O'Connor CM. PMID: 31841369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. Eur J Heart Fail. 2020 Apr; 22(4):683-691. Pandhi P, Ter Maaten JM, Emmens JE, Struck J, Bergmann A, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Cotter G, Davison B, van Veldhuisen DJ, Voors AA. PMID: 31797505.
      View in: PubMed   Mentions: 1     Fields:    
    30. Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF. JACC Heart Fail. 2019 12; 7(12):1042-1053. Lee TC, Qian M, Liu Y, Graham S, Mann DL, Nakanishi K, Teerlink JR, Lip GYH, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Matsumoto K, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Di Tullio MR. PMID: 31779926.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design. Circ Heart Fail. 2019 11; 12(11):e005879. Konstam MA, Udelson JE, Butler J, Klein HU, Parker JD, Teerlink JR, Wedge PM, Saville BR, Ardell JL, Libbus I, DiCarlo LA. PMID: 31722536.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    32. Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. Eur J Heart Fail. 2019 12; 21(12):1561-1570. Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS. PMID: 31646707.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC Heart Fail. 2019 11; 7(11):970-979. Beusekamp JC, Tromp J, Cleland JGF, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Ouwerkerk W, van Veldhuisen DJ, Voors AA, van der Meer P. PMID: 31606364.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. ESC Heart Fail. 2019 12; 6(6):1188-1198. Biegus J, Demissei B, Postmus D, Cotter G, Davison BA, Felker GM, Filippatos G, Gimpelewicz C, Greenberg B, Metra M, Severin T, Teerlink JR, Voors AA, Ponikowski P. PMID: 31568696.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 08 22; 381(8):716-726. Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stepinska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C. PMID: 31433919.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail. 2019 Sep; 21(9):1064-1078. Ahmad T, Miller PE, McCullough M, Desai NR, Riello R, Psotka M, Böhm M, Allen LA, Teerlink JR, Rosano GMC, Lindenfeld J. PMID: 31407860.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development. JACC Heart Fail. 2019 11; 7(11):913-921. Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT. PMID: 31401097.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. J Card Fail. 2019 Nov; 25(11):866-874. Beldhuis IE, Streng KW, van der Meer P, Ter Maaten JM, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Cotter G, Cleland JGF, Davison BA, Givertz MM, Teerlink JR, Bloomfield DM, Voors AA, Damman K. PMID: 31319165.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    39. Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. Eur J Heart Fail. 2019 08; 21(8):1022-1031. Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV. PMID: 31168885.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    40. Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 05 14; 73(18):2345-2353. Psotka MA, Gottlieb SS, Francis GS, Allen LA, Teerlink JR, Adams KF, Rosano GMC, Lancellotti P. PMID: 31072579.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    41. Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972]. Eur J Heart Fail. 2019 Jun; 21(6):819. Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD. PMID: 31222927.
      View in: PubMed   Mentions:    Fields:    
    42. Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey. JACC Heart Fail. 2019 05; 7(5):431-438. Psotka MA, Ammon SE, Fiuzat M, Bozkurt B, Chung ES, Cole RT, Greene SJ, Kraus D, Ky B, McIlvennan CK, Shah P, Teerlink JR, Walsh MN, Jessup M, O'Connor CM. PMID: 30981742.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ESC Heart Fail. 2019 Apr; 6(2):297-307. Lee TC, Qian M, Mu L, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Lip GYH, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S. PMID: 30816013.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction. Eur J Clin Invest. 2019 Feb 23; e13092. Shah N, Qian M, Di Tullio MR, Graham S, Mann DL, Sacco RL, Lip GYH, Labovitz AJ, Ponikowski P, Lok DJ, Anker SD, Teerlink JR, Thompson JLP, Homma S, Freudenberger RS. PMID: 30801690.
      View in: PubMed   Mentions:    Fields:    
    45. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure. Circulation. 2018 09 04; 138(10):1039-1053. Greene SJ, Mentz RJ, Fiuzat M, Butler J, Solomon SD, Ambrosy AP, Mehta C, Teerlink JR, Zannad F, O'Connor CM. PMID: 30354535.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC Heart Fail. 2018 10; 5(5):800-808. Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S. PMID: 30015405.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF. Clin Cardiol. 2018 Jul; 41(7):945-952. Verma AK, Sun JL, Hernandez A, Teerlink JR, Schulte PJ, Ezekowitz J, Voors A, Starling R, Armstrong P, O'Conner CM, Mentz RJ. PMID: 29781109.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Patient-Reported Outcome Instruments in Heart Failure: Are They Preserved? JACC Heart Fail. 2018 07; 6(7):561-563. Psotka MA, Teerlink JR. PMID: 29885950.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). Am J Cardiol. 2018 09 01; 122(5):821-827. Lee TC, Qian M, Lip GYH, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S. PMID: 30037426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018 05 01; 258:185-191. Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA. PMID: 29544928.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data. Circ Heart Fail. 2018 05; 11(5):e004644. Metra M, Cotter G, Senger S, Edwards C, Cleland JG, Ponikowski P, Cursack GC, Milo O, Teerlink JR, Givertz MM, O'Connor CM, Dittrich HC, Bloomfield DM, Voors AA, Davison BA. PMID: 29748350.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC Heart Fail. 2018 04; 6(4):298-307. Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ. PMID: 29525328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J Am Coll Cardiol. 2018 03 06; 71(9):1021-1034. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. PMID: 29495982.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    54. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018 02 27; 137(9):961-972. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. PMID: 29483172.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    55. The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions. Eur J Heart Fail. 2018 06; 20(6):963-972. Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD. PMID: 29464817.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Int J Cardiol. 2018 02 15; 253:91-96. Metra M, Davison BA, Gimpelewicz C, Carubelli V, Felker GM, Filippatos G, Greenberg BH, Hua TA, Liu Z, Pang PS, Ponikowski P, Severin TM, Voors AA, Wang Y, Cotter G, Teerlink JR. PMID: 29306479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. Eur J Heart Fail. 2018 03; 20(3):525-532. Pokorney SD, Al-Khatib SM, Sun JL, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ. PMID: 29266564.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. What's Next for Acute Heart Failure Research? Acad Emerg Med. 2018 Jan; 25(1):85-93. Collins SP, Levy PD, Fermann GJ, Givertz MM, Martindale JM, Pang PS, Storrow AB, Diercks DD, Michael Felker G, Fonarow GC, Lanfear DJ, Lenihan DJ, Lindenfeld JM, Frank Peacock W, Sawyer DM, Teerlink JR, Butler J. PMID: 28990334.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017 11; 106(11):938. Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR. PMID: 28752374.
      View in: PubMed   Mentions:    Fields:    
    60. Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF. Clin Res Cardiol. 2018 Feb; 107(2):170-181. Cotter G, Davison BA, Butler J, Collins SP, Ezekowitz JA, Felker GM, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Senger S, Bharucha D, Goin K, Soergel DG, Pang PS. PMID: 28986703.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    61. Mind the Gap: Current Challenges and Future State of Heart Failure Care. Can J Cardiol. 2017 11; 33(11):1434-1449. McDonald MA, Ashley EA, Fedak PWM, Hawkins N, Januzzi JL, McMurray JJV, Parikh VN, Rao V, Svystonyuk D, Teerlink JR, Virani S. PMID: 29111107.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Systolic blood pressure reduction during the first 24?h in acute heart failure admission: friend or foe? Eur J Heart Fail. 2018 02; 20(2):317-322. Cotter G, Metra M, Davison BA, Jondeau G, Cleland JGF, Bourge RC, Milo O, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJV, Teerlink JR. PMID: 28871621.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Eur Heart J. 2017 Aug 07; 38(30):2364-2373. Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Bharucha D, Goin K, Soergel DG, Felker GM. PMID: 28459958.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    64. Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial. JACC Heart Fail. 2017 08; 5(8):603-610. Teerlink JR, Qian M, Bello NA, Freudenberger RS, Levin B, Di Tullio MR, Graham S, Mann DL, Sacco RL, Mohr JP, Lip GYH, Labovitz AJ, Lee SC, Ponikowski P, Lok DJ, Anker SD, Thompson JLP, Homma S. PMID: 28774396.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039. Greene SJ, Hernandez AF, Dunning A, Ambrosy AP, Armstrong PW, Butler J, Cerbin LP, Coles A, Ezekowitz JA, Metra M, Starling RC, Teerlink JR, Voors AA, O'Connor CM, Mentz RJ. PMID: 28641792.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. Eur J Heart Fail. 2017 10; 19(10):1310-1320. Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, van Veldhuisen DJ, Cotter G, Ezekowitz JA, Khan MAF, Voors AA. PMID: 28639369.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC Heart Fail. 2017 07; 5(7):507-517. Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. PMID: 28624483.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure. Cardiovasc Drugs Ther. 2017 Jun; 31(3):281-293. Liu LCY, Valente MAE, Postmus D, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, van der Meer P, Voors AA. PMID: 28656542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Eur J Heart Fail. 2017 11; 19(11):1520-1529. Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G. PMID: 28560782.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    70. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial. Am Heart J. 2017 Aug; 190:113-122. Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR. PMID: 28760204.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Eur J Heart Fail. 2017 06; 19(6):800-809. Teerlink JR, Voors AA, Ponikowski P, Pang PS, Greenberg BH, Filippatos G, Felker GM, Davison BA, Cotter G, Gimpelewicz C, Boer-Martins L, Wernsing M, Hua TA, Severin T, Metra M. PMID: 28452195.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    72. Heart failure. Lancet. 2017 Oct 28; 390(10106):1981-1995. Metra M, Teerlink JR. PMID: 28460827.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    73. Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. Cerebrovasc Dis. 2017; 44(1-2):43-50. Nakanishi K, Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S. PMID: 28419982.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. Circ Heart Fail. 2017 Apr; 10(4). Butler J, Hamo CE, Udelson JE, O'Connor C, Sabbah HN, Metra M, Shah SJ, Kitzman DW, Teerlink JR, Bernstein HS, Brooks G, Depre C, DeSouza MM, Dinh W, Donovan M, Frische-Danielson R, Frost RJ, Garza D, Gohring UM, Hellawell J, Hsia J, Ishihara S, Kay-Mugford P, Koglin J, Kozinn M, Larson CJ, Mayo M, Gan LM, Mugnier P, Mushonga S, Roessig L, Russo C, Salsali A, Satler C, Shi V, Ticho B, van der Laan M, Yancy C, Stockbridge N, Gheorghiade M. PMID: 28356300.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail. 2017 06; 19(6):739-747. Cleland JGF, Teerlink JR, Davison BA, Shoaib A, Metra M, Senger S, Milo O, Cotter G, Bourge RC, Parker JD, Jondeau G, Krum H, O'Connor CM, Torre-Amione G, van Veldhuisen DJ, McMurray JJV. PMID: 28296139.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. Eur J Heart Fail. 2017 06; 19(6):728-738. Demissei BG, Postmus D, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Dittrich HC, Hillege HL, Voors AA. PMID: 28251755.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    77. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 01; 38(9):648-660. Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W. PMID: 28025189.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    78. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial. Am Heart J. 2017 May; 187:62-69. Pang PS, Teerlink JR, Boer-Martins L, Gimpelewicz C, Davison BA, Wang Y, Voors AA, Severin T, Ponikowski P, Hua TA, Greenberg BH, Filippatos G, Felker GM, Cotter G, Metra M. PMID: 28454809.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Agents with vasodilator properties in acute heart failure. Eur Heart J. 2017 02 01; 38(5):317-325. Singh A, Laribi S, Teerlink JR, Mebazaa A. PMID: 28201723.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017 Jun; 106(6):444-456. Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR. PMID: 28150186.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    81. The safety of sacubitril-valsartan for the treatment of chronic heart failure. Expert Opin Drug Saf. 2017 Feb; 16(2):257-263. Tyler JM, Teerlink JR. PMID: 28060547.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    82. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010. Demissei BG, Cotter G, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Severin TM, Wang Y, Qian M, Teerlink JR, Metra M, Davison BA, Voors AA. PMID: 28133908.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    83. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail. 2017 01; 5(1):1-13. Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz RJ. PMID: 28034373.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    84. Associations of Body Mass Index With Laboratory and Biomarkers in Patients With Acute Heart Failure. Circ Heart Fail. 2017 Jan; 10(1). Streng KW, Ter Maaten JM, Cleland JG, O'Connor CM, Davison BA, Metra M, Givertz MM, Teerlink JR, Ponikowski P, Bloomfield DM, Dittrich HC, Hillege HL, van Veldhuisen DJ, Voors AA, van der Meer P. PMID: 28069685.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction. Handb Exp Pharmacol. 2017; 243:465-490. Psotka MA, Teerlink JR. PMID: 28315072.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    86. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet. 2016 12 10; 388(10062):2895-2903. Teerlink JR, Felker GM, McMurray JJ, Solomon SD, Adams KF, Cleland JG, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcsányi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI, Honarpour N. PMID: 27914656.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    87. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study. Clin Res Cardiol. 2017 Apr; 106(4):280-292. Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Qian M, Voors AA. PMID: 27838739.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial. J Card Fail. 2017 Jan; 23(1):63-71. Sato N, Lam CS, Teerlink JR, Greenberg BH, Tsutsui H, Oh BH, Zhang J, Lefkowitz M, Hua TA, Holbro T, Marshood M, Wang XL, Ge J. PMID: 27825893.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    89. Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials). Am J Cardiol. 2017 Jan 15; 119(2):290-296. Tromp J, Ter Maaten JM, Damman K, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. PMID: 27823598.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    90. Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart. 2017 03; 103(6):407-413. Matsue Y, van der Meer P, Damman K, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Gansevoort RT, Bakker SJ, van der Harst P, Hillege HL, van Veldhuisen DJ, Voors AA. PMID: 27658757.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    91. Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure. J Card Fail. 2017 Mar; 23(3):231-239. Matsue Y, Ter Maaten JM, Struck J, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, van der Meer P, Damman K, Voors AA. PMID: 27663098.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program. Health Qual Life Outcomes. 2016 Sep 15; 14(1):131. Wiklund I, Anatchkova M, Oko-Osi H, von Maltzahn R, Chau D, Malik FI, Patrick DL, Spertus J, Teerlink JR. PMID: 27629389.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. Int J Cardiol. 2016 Dec 01; 224:231-239. Vegter EL, Schmitter D, Hagemeijer Y, Ovchinnikova ES, van der Harst P, Teerlink JR, O'Connor CM, Metra M, Davison BA, Bloomfield D, Cotter G, Cleland JG, Givertz MM, Ponikowski P, van Veldhuisen DJ, van der Meer P, Berezikov E, Voors AA, Khan MA. PMID: 27661412.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    94. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Circ Heart Fail. 2016 09; 9(9). Greene SJ, Hernandez AF, Sun JL, Metra M, Butler J, Ambrosy AP, Ezekowitz JA, Starling RC, Teerlink JR, Schulte PJ, Voors AA, Armstrong PW, O'Connor CM, Mentz RJ. PMID: 27623769.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial. Int J Cardiol. 2016 Nov 15; 223:967-975. Demissei BG, Postmus D, Liu LCY, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Edwards C, Givertz MM, Bloomfield DM, Dittrich HC, Voors AA, Hillege HL. PMID: 27589047.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Acad Emerg Med. 2016 08; 23(8):922-31. Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DE, Lenihan DJ, Lindenfeld JM, Peacock WF, Sawyer DB, Teerlink JR, Butler J. PMID: 27286136.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. Circ Heart Fail. 2016 08; 9(8). Ter Maaten JM, Damman K, Hanberg JS, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Cotter G, Davison B, Cleland JG, Bloomfield DM, Hillege HL, van Veldhuisen DJ, Voors AA, Testani JM. PMID: 27507112.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    98. CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. Eur J Heart Fail. 2016 Oct; 18(10):1261-1266. Ye S, Qian M, Zhao B, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Lip GY, Thompson JL, Homma S. PMID: 27444219.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    99. Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization. J Am Coll Cardiol. 2016 07 19; 68(3):241-248. Desai AS, Claggett BL, Packer M, Zile MR, Rouleau JL, Swedberg K, Shi V, Lefkowitz M, Starling R, Teerlink J, McMurray JJV, Solomon SD. PMID: 27417000.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    100. Patient-Reported Outcomes in Chronic Heart Failure: Applicability for Regulatory Approval. JACC Heart Fail. 2016 10; 4(10):791-804. Psotka MA, von Maltzahn R, Anatchkova M, Agodoa I, Chau D, Malik FI, Patrick DL, Spertus JA, Wiklund I, Teerlink JR. PMID: 27395351.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    101. Acute heart failure in the young: Clinical characteristics and biomarker profiles. Int J Cardiol. 2016 Oct 15; 221:1067-72. Tromp J, Meyer S, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. PMID: 27448534.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    102. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. Stroke. 2016 08; 47(8):2031-7. Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GY, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S. PMID: 27354224.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    103. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2016 Oct; 18(10):1228-1234. Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, Teerlink JR, Desai AS, Lefkowitz M, Shi V, McMurray JJ, Solomon SD. PMID: 27283779.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    104. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. J Card Fail. 2016 Aug; 22(8):618-27. Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DJ, Lenihan DJ, Lindenfeld JM, Peacock WF, Sawyer DB, Teerlink JR, Butler J. PMID: 27262665.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Circ Heart Fail. 2016 06; 9(6). Ter Maaten JM, Valente MA, Damman K, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Bloomfield DM, Cotter G, Davison B, Subacius H, van Veldhuisen DJ, van der Meer P, Hillege HL, Gheorghiade M, Voors AA. PMID: 27266853.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    106. Ivabradine: Role in the Chronic Heart Failure Armamentarium. Circulation. 2016 May 24; 133(21):2066-75. Psotka MA, Teerlink JR. PMID: 27217432.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    107. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. Eur J Heart Fail. 2016 07; 18(7):830-9. Biegus J, Hillege HL, Postmus D, Valente MA, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Massie BM, Metra M, Teerlink JR, Voors AA, O'Connor CM, Ponikowski P. PMID: 27170455.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    108. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail. 2016 08; 18(8):1041-50. Davison BA, Metra M, Senger S, Edwards C, Milo O, Bloomfield DM, Cleland JG, Dittrich HC, Givertz MM, O'Connor CM, Massie BM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. PMID: 27114058.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    109. Lung ultrasound: a 'B-line' to the prediction of decompensated heart failure. Eur Heart J. 2016 Apr 14; 37(15):1252-4. Aras MA, Teerlink JR. PMID: 27080198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    110. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. JACC Heart Fail. 2016 07; 4(7):591-599. Pang PS, Teerlink JR, Voors AA, Ponikowski P, Greenberg BH, Filippatos G, Felker GM, Davison BA, Cotter G, Kriger J, Prescott MF, Hua TA, Severin T, Metra M. PMID: 27039129.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    111. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study. J Am Coll Cardiol. 2016 Mar 29; 67(12):1444-1455. Teerlink JR, Felker GM, McMurray JJV, Ponikowski P, Metra M, Filippatos GS, Ezekowitz JA, Dickstein K, Cleland JGF, Kim JB, Lei L, Knusel B, Wolff AA, Malik FI, Wasserman SM. PMID: 27012405.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    112. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF. Clin Res Cardiol. 2016 Sep; 105(9):727-37. Liu LC, Voors AA, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Chen Y, Greenberg BH, Ponikowski P, Pang PS, Prescott MF, Hua TA, Severin TM, Metra M. PMID: 27017514.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    113. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). Am J Cardiol. 2016 Jun 01; 117(11):1771-8. Metra M, Mentz RJ, Hernandez AF, Heizer GM, Armstrong PW, Clausell N, Corbalan R, Costanzo MR, Dickstein K, Dunlap ME, Ezekowitz JA, Howlett JG, Komajda M, Krum H, Lombardi C, Fonarow GC, McMurray JJ, Nieminen MS, Swedberg K, Voors AA, Starling RC, Teerlink JR, O'Connor CM. PMID: 27108685.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    114. Patient and Facility Variation in Costs of VA Heart Failure Patients. JACC Heart Fail. 2016 07; 4(7):551-558. Yoon J, Fonarow GC, Groeneveld PW, Teerlink JR, Whooley MA, Sahay A, Heidenreich PA. PMID: 26970829.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    115. Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. Circ J. 2016; 80(3):619-26. Kato TS, Di Tullio MR, Qian M, Wu M, Thompson JL, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GY, Levin B, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S. PMID: 26804607.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    116. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail. 2016 04; 18(4):424-32. Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Tang WH, Armstrong PW, Ezekowitz JA, Butler J, McMurray JJ, Teerlink JR, Voors AA, Metra M, Mentz RJ, O'Connor CM, Patel CB, Hernandez AF. PMID: 26707029.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    117. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS. J Card Fail. 2016 Oct; 22(10):815-22. Cotter G, Davison BA, Milo O, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Metra M, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJ, Teerlink JR. PMID: 26721775.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    118. Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure. Expert Opin Investig Drugs. 2016; 25(1):117-27. Liu LC, Dorhout B, van der Meer P, Teerlink JR, Voors AA. PMID: 26587768.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    119. Optimizing clinical use of biomarkers in high-risk acute heart failure patients. Eur J Heart Fail. 2016 Mar; 18(3):269-80. Demissei BG, Valente MA, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Givertz MM, Bloomfield DM, Dittrich H, van der Meer P, van Veldhuisen DJ, Hillege HL, Voors AA. PMID: 26634889.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    120. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. Int J Cardiol. 2016 Feb 01; 204:164-71. Demissei BG, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison B, Givertz MM, Bloomfield DM, Dittrich H, van Veldhuisen DJ, Hillege HL, Voors AA, Cotter G. PMID: 26666342.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    121. Serelaxin and acute heart failure. Heart. 2016 Jan; 102(2):95-9. Tietjens J, Teerlink JR. PMID: 26603680.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    122. MicroRNAs relate to early worsening of renal function in patients with acute heart failure. Int J Cardiol. 2016 Jan 15; 203:564-9. Bruno N, ter Maaten JM, Ovchinnikova ES, Vegter EL, Valente MA, van der Meer P, de Boer RA, van der Harst P, Schmitter D, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Pinto YM, van Veldhuisen DJ, Hillege HL, Berezikov E, Voors AA. PMID: 26569364.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    123. The first prognostic model for stroke and death in patients with systolic heart failure. J Cardiol. 2016 08; 68(2):100-3. Freudenberger RS, Cheng B, Mann DL, Thompson JL, Sacco RL, Buchsbaum R, Sanford A, Pullicino PM, Levin B, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Di Tullio MR, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S. PMID: 26549533.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    124. Letter by Teerlink et al Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity". Circ Heart Fail. 2015 Nov; 8(6):1141. Teerlink JR, Malik FI, Kass DA. PMID: 26578671.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    125. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. Eur J Heart Fail. 2016 06; 18(6):641-9. Emmens JE, Ter Maaten JM, Matsue Y, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Todd J, van Veldhuisen DJ, Hillege HL, Damman K, van der Meer P, Voors AA. PMID: 26511274.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    126. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Future Cardiol. 2015 Sep; 11(5):585-95. Mentz RJ, Velazquez EJ, Metra M, McKendry C, Chiswell K, Fiuzat M, Givertz MM, Voors AA, Teerlink JR, O'Connor CM. PMID: 26403536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Signature of circulating microRNAs in patients with acute heart failure. Eur J Heart Fail. 2016 04; 18(4):414-23. Ovchinnikova ES, Schmitter D, Vegter EL, Ter Maaten JM, Valente MA, Liu LC, van der Harst P, Pinto YM, de Boer RA, Meyer S, Teerlink JR, O'Connor CM, Metra M, Davison BA, Bloomfield DM, Cotter G, Cleland JG, Mebazaa A, Laribi S, Givertz MM, Ponikowski P, van der Meer P, van Veldhuisen DJ, Voors AA, Berezikov E. PMID: 26345695.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    128. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. Eur J Heart Fail. 2015 Nov; 17(11):1133-43. Cotter G, Voors AA, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Milo O, Hua TA, Qian M, Severin TM, Teerlink JR, Metra M, Davison BA. PMID: 26333529.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    129. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015 Dec; 17(12):1262-70. Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, Greenberg BH, Filippatos G, Davison BA, Cotter G, Prescott MF, Hua TA, Lopez-Pintado S, Severin T, Metra M. PMID: 26333655.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    130. Screening for Sleep-Disordered Breathing in Patients Hospitalized for Heart Failure. JACC Heart Fail. 2015 Sep; 3(9):732-3. Oldenburg O, Teerlink JR. PMID: 26362450.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clin Res Cardiol. 2016 Feb; 105(2):145-53. ter Maaten JM, Valente MA, Metra M, Bruno N, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, Hillege HL, Damman K, Voors AA. PMID: 26280875.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    132. In-hospital worsening heart failure. Eur J Heart Fail. 2015 Nov; 17(11):1104-13. Butler J, Gheorghiade M, Kelkar A, Fonarow GC, Anker S, Greene SJ, Papadimitriou L, Collins S, Ruschitzka F, Yancy CW, Teerlink JR, Adams K, Cotter G, Ponikowski P, Felker GM, Metra M, Filippatos G. PMID: 26235192.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    133. Cardiac myosin activators: up and coming. Eur J Heart Fail. 2015 Aug; 17(8):750-2. Psotka MA, Teerlink JR. PMID: 26179667.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    134. Reply: Mode of Death Prevention by Serelaxin. J Am Coll Cardiol. 2015 Jul 07; 66(1):99. Felker GM, Metra M, Teerlink JR. PMID: 26139069.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    135. Team-based Care for Patients Hospitalized with Heart Failure. Heart Fail Clin. 2015 Jul; 11(3):359-70. Larsen PM, Teerlink JR. PMID: 26142635.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. Am J Cardiol. 2015 Sep 15; 116(6):904-12. Ye S, Cheng B, Lip GY, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Qian M, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S. PMID: 26189039.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. Eur J Heart Fail. 2015 Jul; 17(7):697-706. Mentz RJ, Metra M, Cotter G, Milo O, McKendry C, Chiswell K, Davison BA, Cleland JG, Bloomfield DM, Dittrich HC, Fiuzat M, Ponikowski P, Givertz MM, Voors AA, Teerlink JR, O'Connor CM. PMID: 26083764.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    138. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015 Jun; 3(6):429-441. Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. PMID: 25982110.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    139. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. J Card Fail. 2015 Jun; 21(6):519-34. Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, Dickinson MG, Levy P, Stough WG, Sweitzer NK, Teerlink JR, Whellan DJ, Albert NM, Krishnamani R, Rich MW, Walsh MN, Bonnell MR, Carson PE, Chan MC, Dries DL, Hernandez AF, Hershberger RE, Katz SD, Moore S, Rodgers JE, Rogers JG, Vest AR, Givertz MM. PMID: 25953697.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    140. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC Heart Fail. 2015 May; 3(5):395-403. Davison BA, Metra M, Cotter G, Massie BM, Cleland JGF, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O'Connor CM, Teerlink JR. PMID: 25951761.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    141. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. Am Heart J. 2015 Aug; 170(2):290-7. Khazanie P, Heizer GM, Hasselblad V, Armstrong PW, Califf RM, Ezekowitz J, Dickstein K, Levy WC, McMurray JJ, Metra M, Tang WH, Teerlink JR, Voors AA, O'Connor CM, Hernandez AF, Starling R. PMID: 26299226.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    142. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Circ Heart Fail. 2015 May; 8(3):504-9. Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD. PMID: 25850425.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    143. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J. 2015 Feb 14; 36(7):434-9. McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Belohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R. PMID: 25416329.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    144. Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). JACC Heart Fail. 2015 Mar; 3(3):193-201. Felker GM, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Soergel DG, Teerlink JR, Violin JD, Voors AA, Pang PS. PMID: 25650371.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    145. Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. J Card Fail. 2015 Mar; 21(3):179-88. Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Rainisio M, Kobrin I, McMurray JJ, Teerlink JR. PMID: 25573829.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    146. Acute decompensated heart failure update. Curr Cardiol Rev. 2015; 11(1):53-62. Teerlink JR, Alburikan K, Metra M, Rodgers JE. PMID: 24251454.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    147. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015 Jan; 17(1):109-18. Metra M, Mentz RJ, Chiswell K, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Lazzarini V, Mansoor GA, Massie BM, Ponikowski P, Teerlink JR, Voors AA, O'Connor CM. PMID: 25431336.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    148. Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. PLoS One. 2014; 9(11):e113447. Graham S, Ye S, Qian M, Sanford AR, Di Tullio MR, Sacco RL, Mann DL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Labovitz AJ, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S. PMID: 25426862.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med. 2015 Jan; 22(1):94-112. Collins SP, Storrow AB, Levy PD, Albert N, Butler J, Ezekowitz JA, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hiestand B, Hollander JE, Lanfear DE, Pang PS, Peacock WF, Sawyer DB, Teerlink JR, Lenihan DJ. PMID: 25423908.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    150. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015 Jan 06; 131(1):54-61. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Belohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC. PMID: 25403646.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    151. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail. 2014 Dec; 16(12):1362-71. Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR. PMID: 25371147.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    152. Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease. Echocardiography. 2014 Nov; 31(10):1205-12. Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Alokozai D, Johansen KL. PMID: 24828699.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    153. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. J Am Coll Cardiol. 2014 Oct 14; 64(15):1591-8. Felker GM, Teerlink JR, Butler J, Hernandez AF, Miller AB, Cotter G, Davison BA, Filippatos G, Greenberg BH, Ponikowski P, Voors AA, Hua TA, Severin TM, Unemori E, Metra M. PMID: 25301463.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    154. Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. Cerebrovasc Dis. 2014; 38(3):176-81. Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S. PMID: 25300706.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    155. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF. Eur J Heart Fail. 2014 Nov; 16(11):1230-40. Voors AA, Davison BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, Greenberg BH, Pang PS, Levin B, Hua TA, Severin T, Ponikowski P, Metra M. PMID: 25287144.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    156. Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. J Card Fail. 2015 Jan; 21(1):27-43. Collins S, Storrow AB, Albert NM, Butler J, Ezekowitz J, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hiestand B, Hollander JE, Lanfear DE, Levy PD, Pang PS, Peacock WF, Sawyer DB, Teerlink JR, Lenihan DJ. PMID: 25042620.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    157. Serelaxin : a potential new drug for the treatment of acute heart failure. Expert Opin Investig Drugs. 2014 Jul; 23(7):1017-26. Neverova N, Teerlink JR. PMID: 24865798.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    158. Novel drug mechanisms in development for heart failure. Pflugers Arch. 2014 Jun; 466(6):1219-25. Khodjaev SD, Teerlink JR, Malik FI. PMID: 24793049.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    159. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. Eur J Heart Fail. 2014 Jun; 16(6):614-24. Mentz RJ, Cotter G, Cleland JG, Stevens SR, Chiswell K, Davison BA, Teerlink JR, Metra M, Voors AA, Grinfeld L, Ruda M, Mareev V, Lotan C, Bloomfield DM, Fiuzat M, Givertz MM, Ponikowski P, Massie BM, O'Connor CM. PMID: 24771609.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    160. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014 Apr; 2(2):97-112. Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, Shah SJ, Ahmed A, Bonow RO, Cleland JG, Cody RJ, Chioncel O, Collins SP, Dunnmon P, Filippatos G, Lefkowitz MP, Marti CN, McMurray JJ, Misselwitz F, Nodari S, O'Connor C, Pfeffer MA, Pieske B, Pitt B, Rosano G, Sabbah HN, Senni M, Solomon SD, Stockbridge N, Teerlink JR, Georgiopoulou VV, Gheorghiade M. PMID: 24720916.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    161. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. J Card Fail. 2014 Jun; 20(6):407-13. van Deursen VM, Edwards C, Cotter G, Davison BA, Damman K, Teerlink JR, Metra M, Felker GM, Ponikowski P, Unemori E, Severin T, Voors AA. PMID: 24642379.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    162. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev. 2014 Mar; 19(2):135-52. Gheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF, Anker SD, Arnold M, Baschiera F, Cleland JG, Cotter G, Fonarow GC, Giordano C, Metra M, Misselwitz F, Mühlhofer E, Nodari S, Frank Peacock W, Pieske BM, Sabbah HN, Sato N, Shah MR, Stockbridge NL, Teerlink JR, van Veldhuisen DJ, Zalewski A, Zannad F, Butler J. PMID: 23099992.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    163. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014 May 14; 35(19):1284-93. Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL. PMID: 24585267.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    164. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial. Eur Heart J. 2014 Apr; 35(16):1041-50. Filippatos G, Teerlink JR, Farmakis D, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua T, Ponikowski P, Severin T, Unemori E, Voors AA, Metra M. PMID: 24316514.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    165. Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail. 2013 Dec; 15(12):1374-81. Meyer S, van der Meer P, Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA. PMID: 24259042.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    166. Renal function trajectories and clinical outcomes in acute heart failure. Circ Heart Fail. 2014 Jan; 7(1):59-67. Givertz MM, Postmus D, Hillege HL, Mansoor GA, Massie BM, Davison BA, Ponikowski P, Metra M, Teerlink JR, Cleland JG, Dittrich HC, O'Connor CM, Cotter G, Voors AA. PMID: 24281137.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    167. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail. 2014 Jan; 7(1):76-87. Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM, Davison BA, Mansoor GA, Ponikowski P, Voors AA, Cotter G, Metra M, Massie BM, O'Connor CM. PMID: 24281134.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    168. Determinants of hemodialysis-induced segmental wall motion abnormalities. Hemodial Int. 2014 Apr; 18(2):396-405. Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Bolger AF, Alokozai D, Peralta CA, Johansen KL. PMID: 24224868.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    169. Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. Eur Heart J. 2013 Oct; 34(40):3128-36. Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Unemori E, Voors AA, Teerlink JR. PMID: 23999454.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    170. What's new in the treatment of acute heart failure? Curr Cardiol Rep. 2013 Sep; 15(9):393. Selby VN, Teerlink JR. PMID: 23881577.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    171. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. Cerebrovasc Dis. 2013; 36(1):74-8. Pullicino PM, Thompson JL, Sacco RL, Sanford AR, Qian M, Teerlink JR, Haddad H, Diek M, Freudenberger RS, Labovitz AJ, Di Tullio MR, Lok DJ, Ponikowski P, Anker SD, Graham S, Mann DL, Mohr JP, Homma S. PMID: 23921215.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail. 2013 Sep 01; 6(5):988-97. Homma S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie BM, Labovitz AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD. PMID: 23881846.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    173. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail. 2013 Jul; 6(4):727-32. Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF. PMID: 23770519.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    174. Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue. Nephrol Dial Transplant. 2013 Oct; 28(10):2580-5. Dubin RF, Teerlink JR, Schiller NB, Alokozai D, Peralta CA, Johansen KL. PMID: 23743019.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    175. Strategies to prevent postdischarge adverse events among hospitalized patients with heart failure. Heart Fail Clin. 2013 Jul; 9(3):303-20, vi. Psotka MA, Teerlink JR. PMID: 23809417.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    176. Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail. 2013 Jun; 19(6):371-89. Givertz MM, Teerlink JR, Albert NM, Westlake Canary CA, Collins SP, Colvin-Adams M, Ezekowitz JA, Fang JC, Hernandez AF, Katz SD, Krishnamani R, Stough WG, Walsh MN, Butler J, Carson PE, Dimarco JP, Hershberger RE, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Starling RC. PMID: 23743486.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    177. Not time to RELAX in acute heart failure - Authors' reply. Lancet. 2013 May 25; 381(9880):1813-4. Teerlink JR, Metra M. PMID: 23706796.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    178. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013 Apr; 1(2):103-11. Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T. PMID: 24621834.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    179. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol. 2013 May 14; 61(19):1973-81. van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA. PMID: 23500313.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    180. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol. 2013 Jan 15; 61(2):196-206. Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR. PMID: 23273292.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCTClinical Trials
    181. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail. 2013 Apr; 15(4):456-64. Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie BM, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P. PMID: 23159547.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    182. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet. 2013 Jan 05; 381(9860):29-39. Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M. PMID: 23141816.
      View in: PubMed   Mentions: 257     Fields:    Translation:Humans
    183. The clinical effects of levosimendan are not attenuated by sulfonylureas. Scand Cardiovasc J. 2012 Dec; 46(6):330-8. Kivikko M, Nieminen MS, Pollesello P, Pohjanjousi P, Colucci WS, Teerlink JR, Mebazaa A. PMID: 22928945.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    184. Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) study. J Card Fail. 2012 Oct; 18(10):776-83. Goodlin SJ, Wingate S, Albert NM, Pressler SJ, Houser J, Kwon J, Chiong J, Storey CP, Quill T, Teerlink JR. PMID: 23040113.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    185. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012 May 17; 366(20):1859-69. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. PMID: 22551105.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    186. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur J Heart Fail. 2012 Jun; 14(6):605-12. O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie BM. PMID: 22535795.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    187. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. J Card Fail. 2012 Apr; 18(4):265-81. Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC. PMID: 22464767.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    188. The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug Saf. 2012 Mar 01; 35(3):233-44. Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, Miller AB, Piña IL, Thomson S, Varosy PD, Zile MR, Cleland JG, Givertz MM, Metra M, Ponikowski P, Voors AA, Davison BA, Cotter G, Wolko D, Delucca P, Salerno CM, Mansoor GA, Dittrich H, O'Connor CM, Massie BM. PMID: 22339573.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    189. Bile salts for the treatment of heart failure: out on a limb for a gut feeling? J Am Coll Cardiol. 2012 Feb 07; 59(6):593-4. McCabe JM, Teerlink JR. PMID: 22300694.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    190. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail. 2012 Feb; 18(2):94-106. Stevenson WG, Hernandez AF, Carson PE, Fang JC, Katz SD, Spertus JA, Sweitzer NK, Tang WH, Albert NM, Butler J, Westlake Canary CA, Collins SP, Colvin-Adams M, Ezekowitz JA, Givertz MM, Hershberger RE, Rogers JG, Teerlink JR, Walsh MN, Stough WG, Starling RC. PMID: 22300776.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    191. Design of the RELAXin in acute heart failure study. Am Heart J. 2012 Feb; 163(2):149-55.e1. Ponikowski P, Metra M, Teerlink JR, Unemori E, Felker GM, Voors AA, Filippatos G, Greenberg B, Teichman SL, Severin T, Mueller-Velten G, Cotter G, Davison BA. PMID: 22305830.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    192. Running from her past: a case of rapidly progressive dyspnea on exertion. Circulation. 2011 Nov 22; 124(21):2355-61. McCabe JM, Bhave PD, McGlothlin D, Teerlink JR. PMID: 22105198.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    193. Update on the Management of Acute Decompensated Heart Failure. Curr Treat Options Cardiovasc Med. 2011 Oct 06. Majure DT, Teerlink JR. PMID: 21976129.
      View in: PubMed   Mentions:
    194. Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology. 2011; 119(2):96-105. Milo-Cotter O, Cotter-Davison B, Lombardi C, Sun H, Bettari L, Bugatti S, Rund M, Metra M, Kaluski E, Kobrin I, Frey A, Rainisio M, McMurray JJ, Teerlink JR, Cotter-Davison G. PMID: 21912122.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    195. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ Heart Fail. 2011 Nov; 4(6):724-32. O'Connor CM, Fiuzat M, Lombardi C, Fujita K, Jia G, Davison BA, Cleland J, Bloomfield D, Dittrich HC, Delucca P, Givertz MM, Mansoor G, Ponikowski P, Teerlink JR, Voors AA, Massie BM, Cotter G, Metra M. PMID: 21900185.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    196. Medical therapy for chronic heart failure. Lancet. 2011 Aug 20; 378(9792):713-21. Krum H, Teerlink JR. PMID: 21856485.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    197. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet. 2011 Aug 20; 378(9792):667-75. Teerlink JR, Clarke CP, Saikali KG, Lee JH, Chen MM, Escandon RD, Elliott L, Bee R, Habibzadeh MR, Goldman JH, Schiller NB, Malik FI, Wolff AA. PMID: 21856480.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    198. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet. 2011 Aug 20; 378(9792):676-83. Cleland JG, Teerlink JR, Senior R, Nifontov EM, Mc Murray JJ, Lang CC, Tsyrlin VA, Greenberg BH, Mayet J, Francis DP, Shaburishvili T, Monaghan M, Saltzberg M, Neyses L, Wasserman SM, Lee JH, Saikali KG, Clarke CP, Goldman JH, Wolff AA, Malik FI. PMID: 21856481.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCTClinical Trials
    199. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 07; 365(1):32-43. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. PMID: 21732835.
      View in: PubMed   Mentions: 282     Fields:    Translation:Humans
    200. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail. 2011 Sep; 13(9):961-7. Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, Teerlink JR, Greenberg BH, Filippatos G, Teichman SL, Metra M. PMID: 21622980.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    201. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials. 2011 May 25; 12:134. Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. PMID: 21612611.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    202. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol. 2011 May 10; 57(19):1899-907. Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. PMID: 21545947.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    203. Mind or body: evaluating mind-body therapy efficacy in heart failure trials. Arch Intern Med. 2011 Apr 25; 171(8):758-9. Teerlink JR. PMID: 21518943.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    204. Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF. Clin Res Cardiol. 2011 Sep; 100(9):745-53. Davison BA, Cotter G, Sun H, Chen L, Teerlink JR, Metra M, Felker GM, Voors AA, Ponikowski P, Filippatos G, Greenberg B, Teichman SL, Unemori E, Koch GG. PMID: 21416190.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    205. Cardiac inotropes: current agents and future directions. Eur Heart J. 2011 Aug; 32(15):1838-45. Hasenfuss G, Teerlink JR. PMID: 21388993.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    206. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J. 2011 Jun; 32(12):1519-34. Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G. PMID: 21388992.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    207. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am Heart J. 2011 Feb; 161(2):224-32. Gheorghiade M, Pang PS, O'Connor CM, Prasad K, McMurray J, Teerlink JR, Fiuzat M, Sabbah H, Komajda M. PMID: 21315202.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    208. Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study. Cardiology. 2010; 117(3):190-6. Milo-Cotter O, Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Edwards C, Weatherley BD, Greenberg B, Filippatos G, Unemori E, Teichman SL, Cotter G. PMID: 21088400.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    209. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010 Oct 07; 363(15):1419-28. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC. PMID: 20925544.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    210. Acute heart failure clinical drug development: from planning to proof of activity to phase III. Cardiology. 2010; 116(4):292-301. Cotter G, Voors AA, Weatherley BD, Pang PS, Teerlink JR, Filippatos G, Ponikowski P, Milo-Cotter O, Dittrich H, Teichman SL, Adams KF, Gheorghiade M, Metra M. PMID: 20881385.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    211. Ivabradine in heart failure--no paradigm SHIFT…yet. Lancet. 2010 Sep 11; 376(9744):847-9. Teerlink JR. PMID: 20801501.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    212. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study. Eur J Heart Fail. 2010 Oct; 12(10):1130-9. Metra M, Teerlink JR, Felker GM, Greenberg BH, Filippatos G, Ponikowski P, Teichman SL, Unemori E, Voors AA, Weatherley BD, Cotter G. PMID: 20732868.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    213. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010 Jul 27; 56(5):343-51. Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie BM, O'Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J. PMID: 20650354.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    214. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010 Jun; 16(6):e1-194. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. PMID: 20610207.
      View in: PubMed   Mentions: 348     Fields:    Translation:Humans
    215. Relaxin: review of biology and potential role in treating heart failure. Curr Heart Fail Rep. 2010 Jun; 7(2):75-82. Teichman SL, Unemori E, Teerlink JR, Cotter G, Metra M. PMID: 20424993.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    216. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010 Mar 30; 121(12):1393-405. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE. PMID: 20231531.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    217. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail. 2010 May; 12(5):499-507. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. PMID: 20228387.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    218. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. PMID: 20233993.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    219. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail. 2010 Apr; 16(4):277-84. Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA. PMID: 20350693.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    220. A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail Rev. 2009 Dec; 14(4):289-98. Teerlink JR. PMID: 19234787.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    221. Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart Fail Rev. 2009 Dec; 14(4):243-53. Teerlink JR, Metra M, Zacà V, Sabbah HN, Cotter G, Gheorghiade M, Cas LD. PMID: 19876734.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    222. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study. Eur J Health Econ. 2010 Apr; 11(2):185-93. de Lissovoy G, Fraeman K, Teerlink JR, Mullahy J, Salon J, Sterz R, Durtschi A, Padley RJ. PMID: 19582491.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    223. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009 Sep; 30(18):2233-40. Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JE, Zimmer C, Teerlink JR, Maggioni AP, Burnett JC, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M. PMID: 19561338.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    224. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. PMID: 19464405.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    225. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet. 2009 Apr 25; 373(9673):1429-39. Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G. PMID: 19329178.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCTClinical Trials
    226. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Fail Rev. 2009 Dec; 14(4):321-9. Teichman SL, Unemori E, Dschietzig T, Conrad K, Voors AA, Teerlink JR, Felker GM, Metra M, Cotter G. PMID: 19101795.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    227. Vasodilators in the treatment of acute heart failure: what we know, what we don't. Heart Fail Rev. 2009 Dec; 14(4):299-307. Metra M, Teerlink JR, Voors AA, Felker GM, Milo-Cotter O, Weatherley B, Dittrich H, Cotter G. PMID: 19096932.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    228. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol. 2008 Jul 01; 52(1):13-6. Beohar N, Erdogan AK, Lee DC, Sabbah HN, Kern MJ, Teerlink J, Bonow RO, Gheorghiade M. PMID: 18582629.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    229. Role of tolvaptan in acute decompensated heart failure. Expert Rev Cardiovasc Ther. 2008 Jun; 6(5):601-8. Ho JE, Teerlink JR. PMID: 18510477.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    230. Investigating pain in heart failure patients: rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study. J Card Fail. 2008 May; 14(4):276-82. Goodlin SJ, Wingate S, Pressler SJ, Teerlink JR, Storey CP. PMID: 18474339.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    231. Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients. J Am Coll Cardiol. 2008 Mar 18; 51(11):1080-2. Teerlink JR. PMID: 18342225.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    232. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. PMID: 18310669.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    233. Acute heart failure: emerging from the shadows. Crit Care Med. 2008 Jan; 36(1 Suppl):S1-2. Hollenberg SM, Teerlink JR. PMID: 18158468.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    234. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA. 2007 Nov 07; 298(17):2009-19. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I. PMID: 17986694.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    235. Nesiritide: a reappraisal of efficacy and safety. Expert Opin Pharmacother. 2007 Feb; 8(3):361-9. Shah SJ, Teerlink JR. PMID: 17266470.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    236. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007 Feb 13; 49(6):675-83. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. PMID: 17291932.
      View in: PubMed   Mentions: 186     Fields:    Translation:HumansCells
    237. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. . 2007 Apr; 292(4):H1847-60. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. PMID: 17158653.
      View in: PubMed   Mentions:
    238. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. Am J Cardiol. 2006 Oct 02; 98(7A):53L-59L. Greenberg BH, Mehra M, Teerlink JR, Ordronneau P, McCollum D, Gilbert EM. PMID: 17023233.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    239. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 2006 Jun; 11(2):119-28. Zhu BQ, Simonis U, Cecchini G, Zhou HZ, Li L, Teerlink JR, Karliner JS. PMID: 16891289.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    240. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 06; 47(11):2245-52. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. PMID: 16750691.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    241. Endothelins: pathophysiology and treatment implications in chronic heart failure. Curr Heart Fail Rep. 2005 Dec; 2(4):191-7. Teerlink JR. PMID: 16332312.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    242. Pharmacology of new agents for acute heart failure syndromes. Am J Cardiol. 2005 Sep 19; 96(6A):68G-73G. Gheorghiade M, Teerlink JR, Mebazaa A. PMID: 16181825.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    243. Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol. 2005 Sep 19; 96(6A):59G-67G. Teerlink JR. PMID: 16181824.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    244. The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us? Curr Heart Fail Rep. 2005 Aug; 2(2):59-64. Fabi MR, Teerlink JR. PMID: 16036052.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    245. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J. 2005 Jul; 150(1):46-53. Teerlink JR, McMurray JJ, Bourge RC, Cleland JG, Cotter G, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, Van Veldhuisen DJ, Frey A, Rainisio M, Kobrin I. PMID: 16084150.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    246. Nesiritide and worsening of renal function: the emperor's new clothes? Circulation. 2005 Mar 29; 111(12):1459-61. Teerlink JR, Massie BM. PMID: 15795361.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    247. Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther. 2004 Nov; 18(6):421-31. Zhu BQ, Zhou HZ, Teerlink JR, Karliner JS. PMID: 15770429.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    248. A rational approach for the treatment of acute heart failure: current strategies and future options. Curr Opin Cardiol. 2004 May; 19(3):254-63. Sharma M, Teerlink JR. PMID: 15096959.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    249. Novel Pharmacologic Therapy of Heart Failure. Curr Treat Options Cardiovasc Med. 2003 Aug; 5(4):321-335. Hussein SJ, Teerlink JR. PMID: 12834569.
      View in: PubMed   Mentions:
    250. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2003 Jul 02; 42(1):140-7. Torre-Amione G, Young JB, Colucci WS, Lewis BS, Pratt C, Cotter G, Stangl K, Elkayam U, Teerlink JR, Frey A, Rainisio M, Kobrin I. PMID: 12849674.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    251. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION. J Card Fail. 2003 Jun; 9(3):158-63. Teerlink JR, Massie BM. PMID: 12815564.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    252. Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4). J Am Coll Cardiol. 2003 May 07; 41(9):1452-7. O'Connor CM, Gattis WA, Adams KF, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M. PMID: 12742280.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    253. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J. 2003 Feb; 145(2 Suppl):S26-33. Teerlink JR. PMID: 12594449.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    254. Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure. Am Heart J. 2003 Feb; 145(2 Suppl):S47-50. O'Connor CM, Gattis WA, Teerlink JR, Adams KF, Gheorghiade M. PMID: 12594451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    255. Surrogate end points in heart failure trials. Am Heart J. 2003 Feb; 145(2 Suppl):S67-70. Gheorghiade M, Adams KF, Gattis WA, Teerlink JR, Orlandi C, O'Connor CM. PMID: 12594457.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    256. Reversal of left ventricular remodeling: role of the endothelin pathway. J Card Fail. 2002 Dec; 8(6 Suppl):S494-9. Teerlink JR. PMID: 12555164.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    257. Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy? J Card Fail. 2002 Jun; 8(3):124-7. Teerlink JR. PMID: 12140803.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    258. The role of endothelin in the pathogenesis of heart failure. Curr Cardiol Rep. 2002 May; 4(3):206-12. Teerlink JR. PMID: 11960589.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    259. Ventricular remodeling surgery for heart failure: small animals and how to measure an improvement in ventricular function. Ann Thorac Surg. 2002 May; 73(5):1368-70. Teerlink JR, Ratcliffe MB. PMID: 12022519.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    260. Left ventricular volume reduction by radiofrequency heating of chronic myocardial infarction in patients with congestive heart failure. Circulation. 2002 Mar 19; 105(11):1317-22. Victal OA, Teerlink JR, Gaxiola E, Wallace AW, Najar S, Camacho DH, Gutierrez A, Herrera G, Zuniga G, Mercado-Rios F, Ratcliffe MB. PMID: 11901042.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    261. The development of new medical treatments for acute decompensated heart failure. Heart Fail Monit. 2002; 2(4):129-37. Teerlink JR. PMID: 12634887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    262. Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined. Am J Med. 2000 Oct 01; 109(5):431-3. Massie BM, Teerlink JR. PMID: 11020401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    263. Radio frequency heating of chronic ovine infarct leads to sustained infarct area and ventricular volume reduction. J Thorac Cardiovasc Surg. 2000 Jun; 119(6):1194-204. Ratcliffe MB, Wallace AW, Teerlink JR, Hong J, Salahieh A, Sung SH, Keung EC, Lee RJ. PMID: 10838539.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    264. The role of beta-blockers in preventing sudden death in heart failure. J Card Fail. 2000 Jun; 6(2 Suppl 1):25-33. Teerlink JR, Massie BM. PMID: 10908095.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    265. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation. 2000 Jan 4-11; 101(1):40-6. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, Packer M, Massie BM. PMID: 10618302.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    266. Beta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol. 1999 Nov 04; 84(9A):94R-102R. Teerlink JR, Massie BM. PMID: 10568667.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    267. The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. Am Heart J. 1999 Aug; 138(2 Pt 1):193-7. Teerlink JR, Massie BM. PMID: 10426826.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    268. Valvular heart disease in pregnancy. A contemporary perspective. Cardiol Clin. 1998 Aug; 16(3):573-98, x. Teerlink JR, Foster E. PMID: 9742331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    269. Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse isoproterenol-induced myocardial necrosis. J Card Fail. 1998 Mar; 4(1):45-56. Teerlink JR, Pfeffer JM, Pfeffer MA. PMID: 9573503.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    270. Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system. J Cardiovasc Pharmacol. 1996; 27 Suppl 2:S1-8. Teerlink JR. PMID: 8723392.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    271. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am J Physiol. 1995 Jan; 268(1 Pt 2):H432-40. Teerlink JR, Carteaux JP, Sprecher U, Löffler BM, Clozel M, Clozel JP. PMID: 7840293.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    272. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation. 1994 Nov; 90(5):2510-8. Teerlink JR, Löffler BM, Hess P, Maire JP, Clozel M, Clozel JP. PMID: 7955209.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    273. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res. 1994 Jul; 75(1):105-13. Teerlink JR, Pfeffer JM, Pfeffer MA. PMID: 8013068.
      View in: PubMed   Mentions: 36     Fields:    Translation:Animals
    274. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope. J Cardiovasc Pharmacol. 1994; 24 Suppl 3:S32-7. Teerlink JR. PMID: 7700062.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    275. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ Res. 1994 Jan; 74(1):105-14. Teerlink JR, Breu V, Sprecher U, Clozel M, Clozel JP. PMID: 8261583.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    276. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release. Circulation. 1994 Jan; 89(1):393-401. Teerlink JR, Gray GA, Clozel M, Clozel JP. PMID: 8281675.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    277. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol. 1993 Aug; 22(2):615-20. Teerlink JR, Clozel M, Fischli W, Clozel JP. PMID: 8335837.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    278. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol. 1993 Jun; 264(6 Pt 2):H2111-8. Teerlink JR, Clozel JP. PMID: 8322940.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    279. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991 Jun; 121(6 Pt 1):1852-3. Teerlink JR, Goldhaber SZ, Pfeffer MA. PMID: 2035416.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    John's Networks
    Concepts (552)
    Derived automatically from this person's publications.
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _